Sunday 11 October 2026 Export all SBRA data to Excel Powerpack

Sabra Healthcare REIT, Inc.

SBRA Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.

18.96 0.12 +0.64%
Market cap
$4.8B
P/E
72.9×
Fwd P/E
27.3×
Dividend yield
6.33%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
26.76 13.70 10.84 62.76 25.93 0.00 0.00 283.80 32.07 29.14
Piotroski F-Score
5 4 6 5 4 3 4 6 6 5
P/S ratio
6.17 4.94 4.71 6.04 5.98 5.21 4.66 5.07 5.75 5.90
P/FCF ratio
13.47 0.00 6.47 6.39 15.49 9.42 11.36 8.53 18.78 0.00
P/Operating CF
38.17 24.43 37.89 41.83 40.07 30.29 43.09 41.67 50.57 52.28
P/B ratio
1.58 0.59 0.90 1.15 1.05 0.88 0.95 1.17 1.48 1.62
Price to Tangible BV
1.62 0.62 0.94 1.18 1.08 0.89 0.97 1.18 1.49 1.66
EV/Sales
10.68 11.81 9.80 9.59 9.84 9.21 8.59 8.72 9.09 9.06
EV/EBITDA
13.87 15.59 12.31 15.90 13.75 13.79 16.34 14.47 15.67 15.83
EV/Operating CF
15.82 35.52 16.95 17.04 16.60 14.72 16.99 18.79 20.59 20.14
EV/FCF
23.32 (34.25) 13.46 10.16 25.46 16.65 20.93 14.68 29.69 (122.74)
Quick Ratio
0.87 5.73 0.63 0.45 0.45 0.81 0.38 0.34 0.56 0.65
Current Ratio
3.30 6.85 1.83 1.44 1.15 3.60 3.27 3.41 4.32 4.29
Net Debt/EBITDA
5.86 9.07 6.39 5.89 5.38 5.99 7.47 6.07 5.76 5.53
Debt/Assets
53.43% 48.27% 48.49% 39.58% 39.63% 40.13% 43.61% 44.82% 45.58% 46.04%
Debt/Equity
1.19 0.99 0.99 0.69 0.70 0.71 0.82 0.86 0.88 0.90
Asset Turnover
0.11 0.09 0.09 0.10 0.10 0.10 0.11 0.12 0.13 0.14
Operating CF/Net income
2.93 0.92 1.34 5.40 2.56 (3.15) (4.07) 21.85 2.45 2.24
Capex/Depreciation
(0.83) (2.43) 0.49 1.39 (0.70) (0.23) (0.32) 0.46 (0.56) (2.17)
Interest Coverage
2.04 2.21 2.07 1.72 2.51 2.04 1.33 1.83 2.07 2.28
ROE
5.80% 6.65% 8.05% 2.05% 4.01% (3.34%) (2.41%) 0.47% 4.57% 5.59%
ROA
2.54% 3.19% 3.93% 1.08% 2.30% (1.90%) (1.32%) 0.25% 2.37% 2.88%
ROIC
3.77% 1.96% 2.97% 2.33% 2.75% 2.22% 1.60% 2.50% 2.93% 3.04%
Return on Tangible Assets
2.86% 2.25% 4.54% 1.28% 2.61% (2.05%) (1.47%) 0.28% 2.58% 3.06%
Average Days of Receivables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
6.78% 7.94% 5.95% 4.67% 5.47% 6.09% 6.33% 7.33% 7.12% 6.93%
Intangible Assets out of Total Assets
0.01 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01
Share Based Compensation of Revenue
2.88% 2.05% 1.23% 1.48% 1.32% 1.39% 1.19% 1.22% 1.28% 1.47%
Graham Net Nets
(0.70) (1.43) (1.10) (0.61) (0.67) (0.70) (0.76) (0.65) (0.51) (0.47)
Graham Number
17.94 31.95 24.99 11.94 15.79 0.00 0.00 3.69 11.94 13.08
Earnings Yield
3.74% 7.30% 9.22% 1.59% 3.86% (3.77%) (2.70%) 0.35% 3.12% 3.43%
Free Cash Flow Yield
7.43% (6.98%) 15.45% 15.65% 6.46% 10.62% 8.80% 11.73% 5.33% (1.25%)
Revenue per Share
3.99 3.87 3.50 3.54 2.90 2.60 2.71 2.80 3.01 3.21
Operating CF per Share
2.69 1.29 2.02 1.99 1.72 1.63 1.37 1.30 1.33 1.44
Capex per Share
(0.87) (2.62) 0.52 1.35 (0.60) (0.19) (0.26) 0.36 (0.41) (1.68)
Free Cash Flow per Share
1.83 (1.33) 2.55 3.34 1.12 1.44 1.11 1.66 0.92 (0.24)
Cash per Share
0.53 5.56 0.33 0.26 0.32 0.53 0.23 0.20 0.28 0.32
Shareholders Equity per Share
15.56 32.54 18.25 18.64 16.53 15.43 13.23 12.12 11.74 11.70
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
15.56 32.54 18.25 18.64 16.53 15.43 13.23 12.12 11.74 11.70
Free Cash Flow
119.35 (140.83) 453.94 624.94 231.30 315.01 256.36 384.81 215.40 (57.20)
Working Capital
91.06 599.32 78.55 47.73 22.09 371.98 323.07 330.36 391.03 392.91
Capital Expenditures
(56.58) (276.62) 93.35 252.46 (123.55) (41.38) (59.37) 84.24 (95.14) (405.82)
Net Current Asset Value
(1,119.61) (2,893.19) (3,237.18) (2,424.32) (2,408.01) (2,072.20) (2,225.95) (2,116.27) (2,053.47) (2,157.37)
EV/EBIT
21.07 24.68 20.04 29.15 23.40 26.06 38.14 27.26 26.81 27.37
Capex to Sales
0.22 0.68 (0.15) (0.38) 0.21 0.07 0.10 (0.13) 0.14 0.52
Price to Operating Income
12.16 10.32 9.64 18.34 14.23 14.74 20.70 15.83 16.95 17.82
Other line items
Depreciation/Fixed assets
0.03 0.02 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04
Cash ROIC
5.28% (1.90%) 6.93% 10.52% 3.96% 5.35% 4.56% 7.31% 4.12% (1.05%)
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Payables
37.41 71.08 98.68 101.81 127.53 144.63 142.62 139.62 127.44 118.61
Average Assets
2,367.38 4,649.10 6,848.79 6,367.30 6,027.45 5,976.16 5,857.19 5,566.91 5,344.91 5,398.54
Average Common Equity
1,034.68 2,226.37 3,345.97 3,371.60 3,448.84 3,394.38 3,217.96 2,929.46 2,771.91 2,782.54

Fold the line items

Columns are period end dates